# AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
> **ANDA205199** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2019-11-18
## Drug
- **FDA Application Number:** ANDA205199
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
- **Generic name:** AMLODIPINE AND ATORVASTATIN
- **Active ingredients:** AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp.
- **First approval:** 2019-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205199)
---
*AI Analytics · CC0 1.0*